Syringic acid

N.º de catálogoS3629 Lote:S362901

Imprimir

Datos técnicos

Fórmula

C9H10O5
 

Peso molecular 198.17 Número CAS 530-57-4
Solubilidad (25°C)* In vitro DMSO 39 mg/mL (196.8 mM)
Ethanol 39 mg/mL (196.8 mM)
Water 1 mg/mL (5.04 mM)
In vivo (Agregue los solventes al producto individualmente y en orden.)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml significa ligeramente soluble o insoluble.
* Tenga en cuenta que Selleck prueba la solubilidad de todos los compuestos internamente, y la solubilidad real puede diferir ligeramente de los valores publicados. Esto es normal y se debe a ligeras variaciones entre lotes.
* Envío a temperatura ambiente (Las pruebas de estabilidad demuestran que este producto se puede enviar sin medidas de refrigeración.)

Preparación de soluciones madre

Actividad biológica

Descripción Syringic acid (NSC 2129, SYRA) es un Antioxidant potencial utilizado en la medicina tradicional china y es un nutracéutico emergente. Tiene propiedades potenciales anti-Angiogenesis, antiglicantes, antihiperglucémicas, neuroprotectoras y que mejoran la memoria.
In vitro

Syringic acid ameliorates the expressions of TH, DAT and VMAT2 and also significantly attenuates MPTP/p2 induced increased inflammatory markers expression. This compound pretreatment obviously inhibits H2O2-induced RGC-5 cell injury and also decreases H2O2-induced ROS production and MDA content. It may protect RGC-5 cells against apoptosis induced by H2O2 through the activation of PI3K/Akt signaling pathway. This chemical shows a time- and dose-dependent (IC50 = 0.95-1.2 mg/mL) antimitogenic effect against cancer cells with little cytotoxicity on normal fibroblasts (≤20%). It alters cell cycle (S/G2-M or G1/G2-M phases) in a time-dependent manner, induces apoptosis, inhibits DNA-binding activity of NFκB (p ≤ 0.0001), chymotrypsin-like/PGPH (peptidyl-glutamyl peptide-hydrolyzing) (p ≤ 0.0001) and the trypsin-like (p ≤ 0.002) activities of 26S proteasome and angiogenesis. It also differentially sensitizes cancer cells to standard chemotherapies with a marked increase in their sensitivity to camptothecin (500-fold), 5FU (20,000-fold), doxorubicin (210-fold), taxol (3134-fold), vinblastine (1000-fold), vincristine (130-fold) and amsacrine (107-fold) compared to standard drugs alone. This compound exerts its chemotherapeutic and chemo-sensitizing effects through an array of mechanisms including cell-cycle arrest, apoptosis induction, inhibition of cell proliferation, cell migration, angiogenesis, NFκB DNA-binding and proteasome activities.

In vivo

Syringic acid has hepatoprotective effects in various animal models. Oral administration of this compound (10mg/kg of body weight) is reported partial recovery of learning and memory impairment by amyloid β induced neurotoxicity in mice. It also facilitates protective effects on kidney in renal ischemia-reperfusion injury. Antimicrobial activities of this chemical are also reported against various pathogens. Anticancer effects of it are explored on A549 lung carcinoma cells and is found to show apoptotic effects with an IC50 of 30 μM. This acid attenuates the elevation of glycoprotein components in normal and diabetic rats. It may increase insulin secretion of pancreatic β-cells and normalize the plasma glucose level.

Protocolo (de referencia)

Ensayo celular:

[4]

  • Líneas celulares

    SW1116, SW837 and CRL1554 cells

  • Concentraciones

    0-2 mg/mL

  • Tiempo de incubación

    24-72 h

  • Método

    Colorectal cancer cell lines(SW1116 and SW837) and normal human fibroblasts (CRL1554) are plated in 96-well microtiter plates at a cell density of 27×103 cells/well. Cells are incubated for 24-72 h in a culture medium containing increasing concentration of this compound (0-2 mg/mL)at 37℃ in a non-CO2 incubator. After completion of the treatment period, the media are discarded and 100 mL/well of MTT (5 mg/mL membrane filter sterilized culture medium) is added and the plate is incubated for 4 h at 37℃. MTT solution is aspirated and the purple-colored formazan crystals, thus formed, are dissolved in 200mL/well of DMSO:ethanol (1:1; v/v) for 20 min at ambient temperature to lyse the cells and dissolve the colored crystals formed in viable cells.

Estudio en animales:

[2]

  • Modelos animales

    male Wistar rats

  • Dosificaciones

    50 mg/kg

  • Administración

    oral

Referencias

  • http://pubs.acs.org/doi/abs/10.1021/acs.cgd.6b00750
  • http://www.sciencedirect.com/science/article/pii/S2221618913601493
  • https://pubmed.ncbi.nlm.nih.gov/27262802/
  • https://pubmed.ncbi.nlm.nih.gov/23745612/

Selleck's Syringic acid Ha sido citado por 1 Publicación

Syringic acid promotes proliferation and migration of Schwann cells via down-regulating miR-451-5p [ Acta Biochim Biophys Sin (Shanghai), 2019, 51(12):1198-1207] PubMed: 31748779

POLÍTICA DE DEVOLUCIÓN
La Política de Devolución Incondicional de Selleck Chemical garantiza una experiencia de compra en línea fluida para nuestros clientes. Si no está satisfecho con su compra de alguna manera, puede devolver cualquier artículo(s) dentro de los 7 días posteriores a su recepción. En caso de problemas de calidad del producto, ya sean problemas relacionados con el protocolo o con el producto, puede devolver cualquier artículo(s) dentro de los 365 días a partir de la fecha de compra original. Siga las instrucciones a continuación al devolver productos.

ENVÍO Y ALMACENAMIENTO
Los productos Selleck se transportan a temperatura ambiente. Si recibe el producto a temperatura ambiente, tenga la seguridad de que el Departamento de Inspección de Calidad de Selleck ha realizado experimentos para verificar que la colocación a temperatura normal durante un mes no afectará la actividad biológica de los productos en polvo. Después de la recogida, guarde el producto de acuerdo con los requisitos descritos en la hoja de datos. La mayoría de los productos Selleck son estables en las condiciones recomendadas.

NO PARA USO HUMANO, DIAGNÓSTICO VETERINARIO O TERAPÉUTICO.